Chien-Chien Lo, Ed.D. - Publications

Affiliations: 
2010 Texas A&M University - Kingsville 
Area:
Bilingual and Multicultural Education, English as a Second Language Education

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Yu CC, Chen YT, Huang CS, Chueh SJ, Lo CW, Tsai YC. A comprehensive study comparing tack and glue mesh fixation in laparoscopic total extraperitoneal repair for adult groin hernias. Surgical Endoscopy. PMID 31741160 DOI: 10.1007/s00464-019-07234-7  0.48
2019 Yang PS, Lee YH, Chung CF, Chang YC, Wang MY, Lo C, Tsai LW, Shih KH, Lei J, Yu BL, Cheng SH, Huang CS. A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer. Japanese Journal of Clinical Oncology. PMID 31287883 DOI: 10.1093/jjco/hyz102  0.48
2019 Chuang WT, Liu YT, Huang CS, Lo CW, Yao HT, Chen HW, Lii CK. Benzyl Isothiocyanate and Phenethyl Isothiocyanate Inhibit Adipogenesis and Hepatosteatosis in Mice with Obesity Induced by a High-Fat Diet. Journal of Agricultural and Food Chemistry. 67: 7136-7146. PMID 31240929 DOI: 10.1021/acs.jafc.9b02668  0.48
2018 Petrossian K, Kanaya N, Lo C, Hsu PY, Nguyen D, Yang L, Yang L, Warden C, Wu X, Pillai R, Bernal L, Huang CS, Kruper L, Yuan Y, Somlo G, et al. ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer. Oncotarget. 9: 27736-27751. PMID 29963233 DOI: 10.18632/oncotarget.25552  0.48
2018 Kuo SH, Lo C, Chen YH, Lien HC, Kuo WH, Wang MY, Lee YH, Huang CS. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery. Clinical Breast Cancer. PMID 29709458 DOI: 10.1016/j.clbc.2018.04.002  0.48
2018 Petrossian K, Nguyen D, Lo C, Kanaya N, Somlo G, Cui YX, Huang CS, Chen S. Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer. Breast Cancer Research and Treatment. PMID 29623577 DOI: 10.1007/s10549-018-4779-x  0.48
2018 Moon WK, Chang JF, Lo CM, Chang JM, Lee SH, Shin SU, Huang CS, Chang RF. Quantitative breast density analysis using tomosynthesis and comparison with MRI and digital mammography. Computer Methods and Programs in Biomedicine. 154: 99-107. PMID 29249352 DOI: 10.1016/j.cmpb.2017.11.008  0.48
2017 Moon WK, Huang YS, Lee YW, Chang SC, Lo CM, Yang MC, Bae MS, Lee SH, Chang JM, Huang CS, Lin YT, Chang RF. Computer-aided tumor diagnosis using shear wave breast elastography. Ultrasonics. 78: 125-133. PMID 28342323 DOI: 10.1016/j.ultras.2017.03.010  0.48
2017 Huang CS, Yang YW, Chen RT, Lo CM, Lo C, Cheng CF, Lee CS, Chang RF. Whole-Breast Ultrasound for Breast Screening and Archiving. Ultrasound in Medicine & Biology. PMID 28283326 DOI: 10.1016/j.ultrasmedbio.2017.01.009  0.48
2016 Lai SF, Chen YH, Kuo WH, Lien HC, Wang MY, Lu YS, Lo C, Kuo SH, Cheng AL, Huang CS. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy. Annals of Surgical Oncology. PMID 27436202 DOI: 10.1245/s10434-016-5435-5  0.48
2016 Chang RF, Chen HH, Chang YC, Huang CS, Chen JH, Lo CM. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI. Magnetic Resonance Imaging. PMID 26968141 DOI: 10.1016/j.mri.2016.03.001  0.48
Show low-probability matches.